Premium Healthcare Group (CAI:PHGC) Research & Development: E£ Mil (TTM As of . 20)


What is Premium Healthcare Group Research & Development?

Premium Healthcare Group CAI:PHGC -1.14% Research & Development is E£ Mil as of . 20.

Research & Development is the aggregate amount of research and development expenses during the year. Premium Healthcare Group's Research & Development for the six months ended in . 20 was E£0.00 Mil. Premium Healthcare Group does not have enough years/quarters to calculate the Research & Development for the trailing twelve months (TTM) ended in . 20.


Premium Healthcare Group  (CAI:PHGC) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Premium Healthcare Group Research & Development Related Terms


Premium Healthcare Group Research & Development Historical Data

* Premium members only.

The historical data trend for Premium Healthcare Group's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Premium Healthcare Group Research & Development Chart

Premium Healthcare Group Annual Data
Trend
Research & Development

Premium Healthcare Group Semi-Annual Data
Research & Development

Premium Healthcare Group Research & Development Calculation

This is the expense the company spent on research and development.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of E£ Mil mean?
Premium Healthcare Group (CAI:PHGC) has a Research & Development of E£ Mil as of . 20. Research and development expense is the total cost for research and development activities. View historical data on Premium Healthcare Group and its competitors.
Is Premium Healthcare Group's Research & Development too high?
Premium Healthcare Group's current Research & Development is E£ Mil.
How does Premium Healthcare Group's Research & Development compare to TMO and DHR?
Premium Healthcare Group's Research & Development of E£ Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Diagnostics & Research company?
A good Research & Development depends on the Medical Diagnostics & Research industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Premium Healthcare Group and its competitors. Premium Healthcare Group's current Research & Development is E£ Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Premium Healthcare Group stock overvalued right now?
Premium Healthcare Group (CAI:PHGC) has a current Research & Development of E£ Mil. The current Research & Development is E£ Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Premium Healthcare Group (CAI:PHGC), the current Research & Development is E£ Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Premium Healthcare Group Business Description

Address 5 El Dakahlia, El Nasr Street, Port Said, EGY
Premium Healthcare Group Formerly City Lab is a company whose main purpose is to establish, operate and manage medical analysis laboratories, and import supplies and equipments, medical analysis laboratories.